A new trading day began on Friday, with Hims & Hers Health Inc (NYSE: HIMS) stock price up 0.48% from the previous day of trading, before settling in for the closing price of $31.23. HIMS’s price has ranged from $23.97 to $72.98 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 17.22% over the last five years. Meanwhile, its annual earnings per share averaged -10.98%. With a float of $206.71 million, this company’s outstanding shares have now reached $219.12 million.
Hims & Hers Health Inc (HIMS) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Hims & Hers Health Inc is 9.20%, while institutional ownership is 89.21%. The most recent insider transaction that took place on Jan 05 ’26, was worth 306,453. In this transaction Chief Financial Officer of this company sold 9,070 shares at a rate of $33.79, taking the stock ownership to the 91,617 shares. Before that another transaction happened on Dec 22 ’25, when Company’s Chief Financial Officer sold 23,090 for $35.72, making the entire transaction worth $824,710. This insider now owns 94,333 shares in total.
Hims & Hers Health Inc (HIMS) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 0.11 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -10.98% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.25% during the next five years compared to 17.22% growth over the previous five years of trading.
Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators
Here are Hims & Hers Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.23. Likewise, its price to free cash flow for the trailing twelve months is 61.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.54, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.59 in one year’s time.
